16/09/2021 - 09:57 Portfolio Kinaset Therapeutics Announces Dosing Underway in its Phase 1b Study of KN-002 in Healthy Volunteers and Asthma Patients Read more
16/09/2021 - 08:00 Portfolio Gimv leads CHF55.5M ($61M) Series A financing in Anjarium Biosciences to develop novel non-viral gene therapies. Read more
05/08/2021 - 08:41 Portfolio Projective Group acquires specialist data consultancy DTSQUARED Read more
29/07/2021 - 09:00 Portfolio Topas Therapeutics extends Series B round with an additional € 18 million (±$ 22 million) Read more
28/07/2021 - 17:45 Financial Outcome of the optional dividend for the financial year 2020/2021: 63% of the dividend rights on the financial year 2020/2021 are distributed in the form of new ordinary shares, resulting in a capital increase of EUR 28.7 million Read more
27/07/2021 - 13:30 Portfolio The Grandeco Wallfashion Group further expands its business in wall decoration through the integration of Wall!Supply and grows to a turnover of 100 million euros Read more
26/07/2021 - 07:30 Portfolio Gimv transfers stake in Equipe Zorgbedrijven - Dutch group of specialised care clinics - to Nordic Capital Read more
15/07/2021 - 08:00 Portfolio iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients Read more
07/07/2021 - 07:30 Portfolio Gimv transfers Summa, specialist in digital cutting solutions, to Ergon Read more
05/07/2021 - 07:30 Portfolio Gimv enters partnership with Klotter Elektrotechnik and lays foundation for further growth Read more
01/07/2021 - 12:02 Portfolio Biotalys announces successful €54.6 million Initial Public Offering Read more
01/07/2021 - 07:30 Portfolio Cross and Gimv form European market leader for wire mesh solutions Read more
30/06/2021 - 17:45 Financial Report of the Annual and Special General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.50 per share in the form of an optional dividend Read more
30/06/2021 - 07:30 Financial Gimv - Modalités du dividende optionnel. Apport du droit au dividende net en échange de la souscription d'une nouvelle action à 47,25 euros ou 27 droits au dividende relatifs à l’exercice 2020/2021 Read more
16/06/2021 - 17:45 Financial Annual and special general meeting of Gimv on June 30th, 2021 Covid-19 update Read more
08/06/2021 - 07:30 Portfolio Alro Group is taking an important step in its rapid growth as an e-mobility surface treatment specialist Read more
07/06/2021 - 18:00 Portfolio Kind Technologies executes on its strategy to become a leading AgriTech group and sells its pharmaceutical business Read more
01/06/2021 - 12:15 Portfolio Incendin reaches breakthrough in sustainable technology for fire safety Read more
28/05/2021 - 17:00 Financial Convocation of the annual and special general meeting of Gimv on June 30th, 2021 Read more
